These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23780887)

  • 1. Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair.
    Wei D; Parsels LA; Karnak D; Davis MA; Parsels JD; Marsh AC; Zhao L; Maybaum J; Lawrence TS; Sun Y; Morgan MA
    Clin Cancer Res; 2013 Aug; 19(16):4422-32. PubMed ID: 23780887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer.
    Karnak D; Engelke CG; Parsels LA; Kausar T; Wei D; Robertson JR; Marsh KB; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
    Clin Cancer Res; 2014 Oct; 20(19):5085-96. PubMed ID: 25117293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair.
    Lv P; Wang Y; Ma J; Wang Z; Li JL; Hong CS; Zhuang Z; Zeng YX
    Oncotarget; 2014 Sep; 5(17):7512-24. PubMed ID: 25245035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma.
    Gordon IK; Lu J; Graves CA; Huntoon K; Frerich JM; Hanson RH; Wang X; Hong CS; Ho W; Feldman MJ; Ikejiri B; Bisht K; Chen XS; Tandle A; Yang C; Arscott WT; Ye D; Heiss JD; Lonser RR; Camphausen K; Zhuang Z
    Mol Cancer Ther; 2015 Jul; 14(7):1540-1547. PubMed ID: 25939762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma.
    Hao S; Song H; Zhang W; Seldomridge A; Jung J; Giles AJ; Hutchinson MK; Cao X; Colwell N; Lita A; Larion M; Maric D; Abu-Asab M; Quezado M; Kramp T; Camphausen K; Zhuang Z; Gilbert MR; Park DM
    Neuro Oncol; 2018 May; 20(6):799-809. PubMed ID: 29294092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
    Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
    Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.
    Morgan MA; Parsels LA; Zhao L; Parsels JD; Davis MA; Hassan MC; Arumugarajah S; Hylander-Gans L; Morosini D; Simeone DM; Canman CE; Normolle DP; Zabludoff SD; Maybaum J; Lawrence TS
    Cancer Res; 2010 Jun; 70(12):4972-81. PubMed ID: 20501833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776.
    Engelke CG; Parsels LA; Qian Y; Zhang Q; Karnak D; Robertson JR; Tanska DM; Wei D; Davis MA; Parsels JD; Zhao L; Greenson JK; Lawrence TS; Maybaum J; Morgan MA
    Clin Cancer Res; 2013 Aug; 19(16):4412-21. PubMed ID: 23804422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair.
    Kausar T; Schreiber JS; Karnak D; Parsels LA; Parsels JD; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
    Neoplasia; 2015 Oct; 17(10):757-66. PubMed ID: 26585231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1.
    Forester CM; Maddox J; Louis JV; Goris J; Virshup DM
    Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19867-72. PubMed ID: 18056802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
    Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
    Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair.
    Wang Z; Lai ST; Ma NY; Deng Y; Liu Y; Wei DP; Zhao JD; Jiang GL
    Cancer Lett; 2015 Dec; 369(1):192-201. PubMed ID: 26304716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation.
    Gao S; Shan L; Zhang M; Wang Y; Zhan X; Yin Y; Jiang Z; Tao X; Li X; Ye M; Liu Y
    Cell Oncol (Dordr); 2022 Dec; 45(6):1203-1215. PubMed ID: 36136269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.
    Wang J; Chang L; Lai X; Li X; Wang Z; Huang Z; Huang J; Zhang G
    Cell Cycle; 2018; 17(6):671-680. PubMed ID: 29285984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1.
    Vance S; Liu E; Zhao L; Parsels JD; Parsels LA; Brown JL; Maybaum J; Lawrence TS; Morgan MA
    Cell Cycle; 2011 Dec; 10(24):4321-9. PubMed ID: 22134241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.
    Liu L; Wang H; Cui J; Zhang Q; Zhang W; Xu W; Lu H; Liu S; Shen S; Fang F; Li L; Yang W; Zhuang Z; Li J
    Cell Physiol Biochem; 2018; 50(1):317-331. PubMed ID: 30282066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.
    Chang KE; Wei BR; Madigan JP; Hall MD; Simpson RM; Zhuang Z; Gottesman MM
    Mol Cancer Ther; 2015 Jan; 14(1):90-100. PubMed ID: 25376608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.
    Otani Y; Sur HP; Rachaiah G; Namagiri S; Chowdhury A; Lewis CT; Shimizu T; Gangaplara A; Wang X; Vézina A; Maric D; Jackson S; Yan Y; Zhengping Z; Ray-Chaudhury A; Kumar S; Ballester LY; Chittiboina P; Yoo JY; Heiss J; Kaur B; Banasavadi-Siddegowda YK
    Neuro Oncol; 2021 Sep; 23(9):1481-1493. PubMed ID: 33556161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment.
    Zhang C; Hong CS; Hu X; Yang C; Wang H; Zhu D; Moon S; Dmitriev P; Lu J; Chiang J; Zhuang Z; Zhou Y
    Cell Cycle; 2015; 14(13):2100-8. PubMed ID: 25942376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine.
    Im MM; Flanagan SA; Ackroyd JJ; Knapp B; Kramer A; Shewach DS
    Radiat Res; 2016 Nov; 186(5):466-477. PubMed ID: 27740890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.